Any reason why leh?
Cindyteoh ( Date: 28-Apr-2026 15:04) Posted:
|
Big news coming?
Cindyteoh ( Date: 28-Apr-2026 15:04) Posted:
|
Tomorrow 50cents?
I believe should push above .40 +(
In my opinion, many BBs took profit and run road already. And it is dripping blood slowly until it becomes dry. Dyodd.
Looks weak today n EGM coming n market dont like giving out 1,012,322 free shares to ceo again upon EGM
hope it will clear 0.43 first...
piscesmonkey ( Date: 28-Apr-2026 09:16) Posted:
|
After many days of accumulating today should be more up above 40cents?
Time will tell.
In the meantime, to each, his own.
No one knows at this time how it is going to turn out.
 
In the meantime, to each, his own.
No one knows at this time how it is going to turn out.
 
After donkey years only started to moves up recently.
Have to wait another cycle of donkey years to come for another excitement.
In the meantime, will continue to Lao Sai everyday.
Have to wait another cycle of donkey years to come for another excitement.
In the meantime, will continue to Lao Sai everyday.
Typically, it will take a couple of years to get FDA approval - deoneding also on how fast cllinical trial can be completed.
IX BiPharma' s sublingual painkiller is already at Phase 3.
Also in IX BioPharma case, the EUA allows usage first.
Think the commercialisation  will be fast-track.
Also the funding from US DoD means that is little to no risk at all.
One huge potential is the buying out/taking over by bigger pharma companies.
IX BiPharma' s sublingual painkiller is already at Phase 3.
Also in IX BioPharma case, the EUA allows usage first.
Think the commercialisation  will be fast-track.
Also the funding from US DoD means that is little to no risk at all.
One huge potential is the buying out/taking over by bigger pharma companies.
JAMMIE ( Date: 27-Apr-2026 14:32) Posted:
|
Atleast 2-3 years away. The FDA approval itself is set for 2028 if I am not mistaken.  so a long way to go. The recent run up in price was because of the analysts giving a TP of $1 and the recent funding that came from US Govt. There is defninite potential but for the long term. Because it has climbed up very quickly any entry point right now is quite a risk. Shouldideally want atleast 2 qrts and follow the mngt commentary before deciding tio lock money for the long term in this one. 
Sgvale ( Date: 27-Apr-2026 13:31) Posted:
|
Fake rise so far, the real bbs have not come out to play yet?
Will this go for US listing since US defence set its interest.?
Today got power
It is $2+ after 2 for 1 bonus issue.
Original investor before the bonus issue would
have earned a value o about $7.
Original investor before the bonus issue would
have earned a value o about $7.
JAMMIE ( Date: 24-Apr-2026 15:08) Posted:
|
Its all in the details. You need to do your own due diligence.  The main catalyst is the FDA approval and thats somewhere in 2027-2028. So you have to factor that do they have the money to keep going for next 2-3 years, will they need to raise money again etc etc. the analysts have given a target price of SGD 1.00 but there is no time period defined. Maybe eventually it wil lreach there. Look at Oiltek, it listed at around 11c and now is $2.00+ in about 3 years. 
 
 
Sgvale ( Date: 24-Apr-2026 14:42) Posted:
|
Is the Co. finance and prospect better compared to last time it listed at 0.46?
JAMMIE ( Date: 24-Apr-2026 13:29) Posted:
|
u can get all this info from AI. 
 
 
At its July 2015 initial public offering (IPO) on the Singapore Exchange (SGX) Catalist board,  iX Biopharma Ltd.  listed at a price of  S$0.46 per share. 
The Straits Times  +1
The company offered a total of  65.5 million new shares  during its debut. This offering was broken down into two tranches: 
The Business Times  +1
- Placement shares:  64.5 million shares were allocated to institutional and other investors.
- Public subscription:  1.0 million shares were made available to the general public.
Since its IPO in July 2015, ordinary shareholders of iX Biopharma have experienced significant dilution, with the total number of issued shares increasing by approximately  78%. 
- IPO Share Count (July 2015):  The company listed with an enlarged share capital of  ~589 million shares.
- Current Share Count (April 2026):  Following the exercise of warrants and various placements, the total issued shares reached  1,048,324,529
Impact on Shareholder Ownership
If you held 1% of the company at IPO (approx. 5.89 million shares), your ownership would have dropped to roughly  0.56%  today if you did not participate in subsequent rights issues or placements.
Despite this dilution, the  Singapore Exchange  (SGX) and  Yahoo Finance  reports show that the share price recently recovered to its IPO level of  S$0.46  in April 2026, driven by a  US$40.95 million  contract from the US Department of Defense.
Sgvale ( Date: 24-Apr-2026 13:12) Posted:
|
What's the ipo price?
RODSTEWARD ( Date: 24-Apr-2026 10:31) Posted:
|